Works matching IS 03065251 AND DT 1996 AND VI 42 AND IP 2
1
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 163, doi. 10.1046/j.1365-2125.1996.03864.x
- SKEITH, K.J.;
- DASGUPTA, M.;
- LANGE, R.;
- JAMALI, F.
- Article
2
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 147, doi. 10.1046/j.1365-2125.1996.03642.x
- HERMAN, ROBERT J.;
- WILKINSON, GRANT R.
- Article
3
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 246, doi. 10.1046/j.1365-2125.1996.40518.x
- DAVIS, J. D.;
- DIXON, R.;
- KHAN, A. Z.;
- TOON, S.;
- ROLAN, P. E.;
- POSNER, J.
- Article
4
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 207, doi. 10.1046/j.1365-2125.1996.39310.x
- KOCH, K. M.;
- KERR, B. M.;
- GOODING, A. E.;
- DAVIS, I. M.
- Article
5
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 236, doi. 10.1046/j.1365-2125.1996.39715.x
- MORTLOCK, S.-A.;
- LANGLEY, R. W.;
- BRADSHAW, C. M.;
- SZABADI, E.
- Article
6
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 253, doi. 10.1046/j.1365-2125.1996.41420.x
- Article
7
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 143, doi. 10.1046/j.1365-2125.1996.d01-3294.x
- Article
8
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 201, doi. 10.1046/j.1365-2125.1996.03929.x
- KOCH, K. M.;
- DAVIS, I. M.;
- GOODING, A. E.;
- YIN, Y.
- Article
9
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 157, doi. 10.1046/j.1365-2125.1996.03563.x
- ZOMORODI, K.;
- HOUSTON, J. B.
- Article
10
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 195, doi. 10.1046/j.1365-2125.1996.04038.x
- HAAGSMA, CEES J.;
- RUSSEL, FRANS G. M.;
- VREE, TOM B.;
- VAN RIEL, PIET L. C. M.;
- VAN DE PUTTE, LEVINUS B. A.
- Article
11
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 233, doi. 10.1046/j.1365-2125.1996.39114.x
- GRAU, JUAN J.;
- ESTAPÉ, JORGE;
- CUCHI, MARÍA A.;
- FÍRVIDA, JOSÉ L.;
- BLANCH, JOSÉ L.;
- ASCASO, CARLOS
- Article
12
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 187, doi. 10.1046/j.1365-2125.1996.04047.x
- MEGNIEN, JEAN LOUIS;
- SIMON, ALAIN;
- ANDRIANI, ANTONIA;
- SEGOND, PATRICK;
- JEANNIN, SOPHIE;
- LEVENSON, JAIME
- Article
13
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 179, doi. 10.1046/j.1365-2125.1996.03956.x
- Article
14
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 213, doi. 10.1046/j.1365-2125.1996.40211.x
- GARCÍA RODRÍGUEZ, LUIS A.;
- MANNINO, SALVATORE;
- WALLANDER, MARI-ANN;
- LINDBLOM, BERTIL
- Article
15
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 171, doi. 10.1046/j.1365-2125.1996.03505.x
- WENSING, G.;
- HEINIG, R.;
- KUHLMANN, J.
- Article
16
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 239, doi. 10.1046/j.1365-2125.1996.39016.x
- KERR, J. S.;
- POWELL, J.;
- HINDMARCH, I.
- Article
17
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 249, doi. 10.1046/j.1365-2125.1996.40619.x
- GUGLER, R.;
- HARTMANN, M.;
- RUDI, J.;
- BROD, I.;
- HUBER, R.;
- STEINIJANS, V. W.;
- BLIESATH, H.;
- WURST, W.;
- KLOTZ, U.
- Article
18
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 217, doi. 10.1046/j.1365-2125.1996.39412.x
- WANG, T.;
- KAUMANN, A. J.;
- BROWN, M. J.
- Article
19
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 242, doi. 10.1046/j.1365-2125.1996.39817.x
- MAZOIT, JEAN XAVIER;
- BENHAMOU, DAN;
- VEILLETTE, YVES;
- SAMII, KAMRAN
- Article